Addressing the public health burden of respiratory viruses: the Battle against Respiratory Viruses (BRaVe) Initiative

Journal article

Given the enormous estimated burden of respiratory virus infections worldwide, a substantial number of research priorities exist in order to better understand their epidemiology, pathogenesis, prevention and clinical management across different populations and resource settings. New therapeutics and specific vaccines for noninfluenza respiratory virus infections could provide enormous benefits in reducing the morbidity and mortality associated with these frequent infections and provide the foundation for responding to newly emerging threats. The BRaVe Initiative is a new WHO-led effort to catalyze multidisciplinary research on strategies to prevent and treat medically important respiratory virus infections with the goal of timely integration of scientific advances and technical innovations into public health practice. © 2013 Future Medicine Ltd.

Authors: Legand, A; Briand, S; Shindo, N; Brooks, W; Jong, D

• Journal: Future Virology
• Volume: 8
• Issue: 10
• Pages: 953-968
• Publication date: 2013-10-01
• DOI: 10.2217/fvl.13.85
• EISSN: 1746-0808
• ISSN: 1746-0794
• Language: English
• Keywords: pneumonia; antivirals; vaccines; influenza virus; severe acute respiratory infection; WHO research agenda; emerging respiratory viruses; public health policies; respiratory syncytial virus; respiratory viral infections